All lobbying filings
Hooper, Lundy & Bookman, P.C.
Hooper, Lundy & Bookman, P.C. filed a Q1 report for Government Counsel, LLC (OBO) Prime Therapeutics on April 20, 2026, reporting $10,000 in lobbying income.
Lobbying for Government Counsel, LLC (OBO) Prime Therapeutics · ​Public Policy and Government Advisory Firm
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Florida
Lobbyists on this filing
1
-
LISA LAYMANPreviously held: SPA, Sen. Stabenow (2005-2007); SPA Sen. Graham (2001-2004); LA, Sen. Bryan (2000); LA, Sen. Chafee (1997-1999); CBO, PA (1992-1996)
Government bodies contacted
2
Lobbying activity
2
H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026; Public Law 119-75 - The Consolidated Appropriations Act, provisions regulating pharmacy benefit manager practices.
S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).